Biomarkers and endpoints for dry AMD trials

被引：0
|
作者：
Sadda, Srinivas R. [1 ,2 ]
机构：
[1] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA
[2] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
991
引用
收藏
页数：2
相关论文
共 50 条
  • [31] ENDPOINTS IN CLINICAL TRIALS
    Priker, R.
    LUNG CANCER, 2009, 64 : S22 - S22
  • [32] Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers
    Morel, Alix
    Lebard, Pierre
    Dereux, Alexandra
    Azuar, Julien
    Questel, Frank
    Bellivier, Frank
    Marie-Claire, Cynthia
    Fatseas, Melina
    Vorspan, Florence
    Bloch, Vanessa
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [33] Utility and costs of surrogate endpoints (SEs) and biomarkers in phase I oncology trials.
    Goulart, BHL
    Roberts, TG
    Clark, JW
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 522S - 522S
  • [34] Monotherapy trials: endpoints
    Mattson, RH
    EPILEPSY RESEARCH, 2001, 45 (1-3) : 109 - 117
  • [35] Bilateral evolution of OCT biomarkers in dry AMD: Long-term follow up study
    Samanta, Anindya
    Arora, Supriya
    Jhingan, Mahima
    Singh, Sumit
    Amarasekera, Sohani
    Tucci, Davide
    Cagini, Carlo
    Lupidi, Marco
    Chhablani, Jay
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (03) : 683 - 690
  • [36] Bilateral evolution of OCT biomarkers in dry AMD: long-term follow up study
    Samanta, Anindya
    Arora, Supriya
    Jhingan, Mahima
    Singh, Sumit
    Amarasekera, Sohani
    Tucci, Davide
    Cagini, Carlo
    Lupidi, Marco
    Chhablani, Jay
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [37] Carcinogen-DNA and protein adducts: Biomarkers for cohort selection and modifiable endpoints in chemoprevention trials
    Kensler, TW
    Groopman, JD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, : 85 - 91
  • [38] Hot Topics in Dry AMD
    Narayanan, Raja
    Kuppermann, Baruch D.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (04) : 542 - 546
  • [39] The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials
    Kumar-Singh, Rajendra
    EXPERIMENTAL EYE RESEARCH, 2019, 184 : 266 - 277
  • [40] New hope for dry AMD?
    James B. Evans
    Basharut A. Syed
    Nature Reviews Drug Discovery, 2013, 12 : 501 - 502
12345